| S-1505 | Stresscopin-Related Peptide (6-43) (human), SRP (6-43) (human) | C183H324N58O51 | 4152.95 | H-Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2 | |
| S-1506 | (Tyr0)-Stresscopin-Related Peptide (human), (Tyr0)-SRP (human) | C214H367N69O59 | 4850.7 | H-Tyr-His-Pro-Gly-Ser-Arg-Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2 | |
| S-1601 | Substance P | C63H98N18O13S | 1347.65 | 33507-63-0 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1601-2 | Biotinyl-Substance P | C73H112N20O15S2 | 1573.95 | 87468-58-4 | Biotinyl-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1601-3 | Substance P (free acid) | C63H97N17O14S | 1348.64 | 71977-09-8 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-OH |
| S-1602 | Substance P-methyl ester | C64H99N17O14S | 1362.66 | 76260-78-1 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-OMe |
| S-1601-4 | (p-Bz-Phe8)-Substance P, (Bpa8)-Substance P | C70H102N18O14S | 1451.76 | 130409-05-1 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-p-Bz-Phe-Gly-Leu-Met-NH2 |
| S-1601-5 | (Nle11)-Substance P | C64H100N18O13 | 1329.61 | 57462-42-7 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Nle-NH2 |
| S-1601-6 | (Sar9,Met(O2)11)-Substance P | C64H100N18O15S | 1393.68 | 110880-55-2 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met(O2)-NH2 |
| S-1601-7 | (Tyr8)-Substance P | C63H98N18O14S | 1363.65 | 55614-10-3 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Met-NH2 |
| S-1603 | Substance P (1-4) | C22H40N8O5 | 496.61 | 57468-16-3 | H-Arg-Pro-Lys-Pro-OH |
| S-1604 | Substance P (1-7) | C41H65N13O10 | 900.05 | 68060-49-1 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-OH |
| S-1605 | Substance P (1-9) | C52H77N15O12 | 1104.28 | 57468-17-4 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-OH |
| S-1606 | Substance P (2-11) | C57H86N14O12S | 1191.46 | 53749-61-4 | H-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1607 | Substance P (4-11) | C46H67N11O10S | 966.17 | 53749-60-3 | H-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1607-2 | (D-Ala4)-Substance P (4-11) | C44H65N11O10S | 940.13 | 81381-50-2 | H-D-Ala-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1608 | Substance P (5-11) | C41H60N10O9S | 869.06 | 51165-09-4 | H-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1608-2 | (D-Glu5,D-Trp7·9·10)-Substance P (5-11) | C57H66N12O10S | 1111.29 | 289632-61-7 | H-D-Glu-Gln-D-Trp-Phe-D-Trp-D-Trp-Met-NH2 |
| S-1608-3 | (Pyr5)-Substance P (5-11) | C41H57N9O9S | 852.03 | 56104-22-4 | Pyr-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1608-4 | (Pyr5,N-Me-Phe8,Sar9)-Substance P (5-11) | C43H61N9O9S | 895.09 | 77128-69-9 | Pyr-Gln-Phe-N-Me-Phe-Sar-Leu-Met-NH2 |
| S-1609 | Substance P (6-11) | C41H60N10O9S | 740.93 | 51165-09-4 | H-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1609-2 | (Pyr6)-Substance P (6-11) | C36H49N7O7S | 723.89 | 61123-13-5 | Pyr-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1609-3 | (Pyr6,Pro9)-Substance P (6-11), Septide | C39H53N7O7S | 763.96 | 79775-19-2 | Pyr-Phe-Phe-Pro-Leu-Met-NH2 |
| S-1609-4 | Succinyl-(Asp6,N-Me-Phe8)-Substance P (6-11), Senktide | C40H55N7O11S | 841.98 | 106128-89-6 | Suc-Asp-Phe-N-Me-Phe-Gly-Leu-Met-NH2 |
| S-1610 | Substance P (7-11) | C31H44N6O5S | 612.79 | 51165-05-5 | H-Phe-Phe-Gly-Leu-Met-NH2 |
| S-1610-2 | δ-Aminovaleryl-(Pro9,N-Me-Leu10)-Substance P (7-11), GR 73632 | C40H59N7O6S | 766.02 | 133156-06-6 | δ-Aminovaleryl-Phe-Phe-Pro-N-Me-Leu-Met-NH2 |
| S-1611 | Substance P (9-11) | C13H26N4O3S | 319.4 | 40297-96-9 | H-Gly-Leu-Met-NH2 |
| S-1701 | (D-Arg1,D-Phe5,D-Trp7·11)-Substance P | C75H101N19O12 | 1460.75 | H-D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-Gly-Leu-D-Trp-NH2 | |
| S-1702 | (D-Arg1,D-Phe5,D-Trp7·9,Leu11)-Substance P | C79H109N19O12 | 1516.86 | 96736-12-8 | H-D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 |
| S-1703 | (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P | C67H102N20O13S | 1427.74 | 115760-58-2 | H-D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Phe-Phe-D-His-Leu-Met-NH2 |
